Sirius NeoSight

📍 Lyon, France🗓 Founded 2023👥 7 employees💰 Last funded Feb 2025
Biotechnology Research
LinkedIn
Sirius NeoSight est une société innovante de rupture technologique qui a pour ambition de devenir un acteur incontournable dans la détection des néo-cancers infracliniques, des rechutes et le suivi thérapeutique des patients proposant ainsi un nouveau regard aux médecins sur l’efficacité thérapeutique mise en oeuvre. Sirius NeoSight exploite une technologie de rupture issue brevetée issue d’un consortium de laboratoires académiques experts du domaine.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Sirius NeoSight?
Sirius NeoSight has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Sirius NeoSight last raise funding?
The most recent investment in Sirius NeoSight recorded on gritt.io was in February 2025.
When was Sirius NeoSight founded?
Sirius NeoSight was founded in 2023.
What industry is Sirius NeoSight in?
Sirius NeoSight operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sirius NeoSight based?
Sirius NeoSight is headquartered in Lyon, France.